Recombinant Carassius auratus NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L)

What is MT-ND4L and what role does it play in mitochondrial function?

MT-ND4L (NADH-ubiquinone oxidoreductase chain 4L) is an accessory subunit of mitochondrial Complex I, which is crucial for oxidative phosphorylation. This protein is encoded by the mitochondrial genome and plays a significant role in the first step of the electron transport process. Specifically, MT-ND4L contributes to the transfer of electrons from NADH to ubiquinone, which is essential for generating the electrochemical gradient that drives ATP synthesis. The protein is embedded in the inner mitochondrial membrane as part of Complex I, which is one of several enzyme complexes necessary for oxidative phosphorylation . In Carassius auratus (goldfish), the MT-ND4L protein consists of 98 amino acids and contributes to the proper assembly and function of Complex I .

What is the amino acid sequence and structural features of Carassius auratus MT-ND4L?

The full amino acid sequence of Carassius auratus MT-ND4L consists of 98 amino acids and is: MTPVHFSFSAFILGLMGLAFHRTHLISALLCLEGMMLSLFIALALWALQFESTGFSTAPMLLLAFSACEASTGLALLVATARTHGTDRLQNLNLLQC . This protein is predominantly hydrophobic and contains transmembrane domains that anchor it within the inner mitochondrial membrane. The protein's structure features multiple membrane-spanning regions that allow it to function within the lipid bilayer of the mitochondrial membrane. Structural analyses suggest that MT-ND4L contributes to the proton-pumping mechanism of Complex I, although its exact structural role is still being elucidated through ongoing research .

How is recombinant Carassius auratus MT-ND4L typically produced for research purposes?

Recombinant Carassius auratus MT-ND4L is typically produced in expression systems such as yeast or E. coli. Based on available commercial products, the protein is often expressed with a tag (commonly His-tag) to facilitate purification, although the tag type may vary depending on the production process . The recombinant protein production process generally involves:

• Gene synthesis or cloning of the MT-ND4L coding sequence

• Insertion into an appropriate expression vector

• Transformation into the expression host (yeast systems appear to be commonly used for this particular protein)

• Induction of protein expression

• Cell lysis and protein extraction

• Purification using affinity chromatography (based on the attached tag)

• Quality control assessment, typically including SDS-PAGE to confirm purity (>85% purity is standard)

The resulting recombinant protein is then typically provided in a stabilized form, either as a lyophilized powder or in solution with glycerol to prevent freeze-thaw damage .

How do mutations in MT-ND4L affect mitochondrial function and what are their implications for disease?

Mutations in MT-ND4L can significantly disrupt Complex I function, leading to impaired oxidative phosphorylation and mitochondrial dysfunction. One well-documented mutation in MT-ND4L is the T10663C (Val65Ala) variant, which has been identified in several families with Leber hereditary optic neuropathy (LHON) . This mutation changes the amino acid valine to alanine at position 65 of the protein.

• The mutation may affect the stability or assembly of Complex I

• It may alter electron transport efficiency, potentially increasing reactive oxygen species production

• The mutation might specifically affect highly energy-dependent cells like retinal ganglion cells, explaining the tissue-specific nature of LHON

This example illustrates how even single amino acid changes in MT-ND4L can have profound physiological consequences, highlighting the protein's critical role in normal mitochondrial function .

How does MT-ND4L compare to other Complex I subunits like MT-ND4, and what is their functional relationship?

MT-ND4L and MT-ND4 are both mitochondrially-encoded subunits of Complex I, but they differ in size and specific functions. MT-ND4 is substantially larger (approximately 459 amino acids in humans) compared to MT-ND4L (approximately 98 amino acids) .

Functional relationships between these subunits include:

• Both contribute to the proton-pumping mechanism of Complex I

• They are located in proximity within the membrane domain of Complex I

• MT-ND4 mutations are more commonly associated with LHON (particularly the G11778A variant, which is responsible for approximately 70% of all LHON cases worldwide)

• Both subunits are essential for proper Complex I assembly and stability

These subunits work in concert with other Complex I components to facilitate NADH oxidation and electron transfer to ubiquinone, ultimately contributing to the electrochemical gradient that drives ATP synthesis .

What can knockout models tell us about MT-ND4L function, and how do they inform our understanding of mitochondrial disorders?

While specific MT-ND4L knockout models are not extensively documented in the provided search results, insights can be gained from studies of related Complex I subunit knockouts, such as Ndufs4 knockout mouse models used to study Leigh syndrome .

These knockout models demonstrate:

• The critical importance of Complex I function for neurological health

• Tissue-specific effects of mitochondrial dysfunction, with the central nervous system being particularly vulnerable

• The value of animal models in testing potential therapeutic interventions for mitochondrial disorders

By extension, similar approaches could be applied to study MT-ND4L function, potentially creating tissue-specific knockouts or introducing specific mutations (such as the T10663C LHON-associated variant) to better understand the protein's role in normal physiology and disease .

What are the optimal storage and handling conditions for recombinant MT-ND4L proteins?

Based on manufacturer recommendations for recombinant MT-ND4L proteins, the following storage and handling protocols are advised:

• Storage temperature: -20°C to -80°C for long-term storage, with -80°C preferred for maximum stability

• Storage buffer: Typically Tris-based buffers with glycerol (often 50%) as a cryoprotectant

• Shelf life: Approximately 6 months for liquid formulations and 12 months for lyophilized formulations when stored properly

• Working aliquots: Store at 4°C for up to one week to avoid repeated freeze-thaw cycles

• Reconstitution (for lyophilized products): Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL, then add glycerol (5-50% final concentration) before aliquoting for long-term storage

It is strongly recommended to centrifuge vials briefly before opening to ensure the contents are at the bottom of the tube. Repeated freeze-thaw cycles should be strictly avoided as they can significantly compromise protein integrity and activity .

What experimental approaches can be used to assess the functional activity of recombinant MT-ND4L?

• Complex I activity assays: Measuring NADH:ubiquinone oxidoreductase activity in reconstituted systems or membrane preparations

• Protein incorporation studies: Assessing the ability of recombinant MT-ND4L to incorporate into Complex I in mitochondrial preparations from cells with MT-ND4L mutations or deficiencies

• Structural integrity assessment: Using circular dichroism or other spectroscopic methods to confirm proper protein folding

• Membrane integration assays: Evaluating the protein's ability to properly insert into lipid membranes

• Protein-protein interaction studies: Investigating interactions with other Complex I subunits using techniques such as co-immunoprecipitation or proximity ligation assays

The choice of method depends on the specific research question, with complex I activity assays being particularly valuable for functional studies in the context of disease-associated mutations .

What quality control parameters should researchers evaluate when working with recombinant MT-ND4L?

When working with recombinant MT-ND4L, researchers should evaluate several key quality control parameters:

Additionally, batch-to-batch consistency should be evaluated when receiving new lots of the protein, particularly for long-term studies where experimental comparability is essential .

How can recombinant MT-ND4L be used in research on Leber hereditary optic neuropathy (LHON)?

Recombinant MT-ND4L can serve as a valuable tool in LHON research through multiple applications:

• Structural studies: Wild-type and mutant (e.g., T10663C/Val65Ala) recombinant proteins can be used for comparative structural analyses to understand how the mutation affects protein conformation

• Functional reconstitution: Recombinant proteins can be used in reconstitution experiments to assess how mutations affect Complex I assembly and activity

• Protein-protein interaction studies: Investigating how mutations alter interactions with other Complex I subunits

• Development of screening assays: Creating assays to identify compounds that might restore function to mutant MT-ND4L

• Antigen production: Generating antibodies for detection and quantification of MT-ND4L in patient samples

These applications can provide insights into the molecular mechanisms underlying LHON and potentially identify targets for therapeutic intervention .

What animal models are available for studying MT-ND4L-related mitochondrial disorders?

While the search results don't specifically mention animal models focused on MT-ND4L mutations, they do provide information about animal models for related mitochondrial disorders that could inform MT-ND4L research:

• Ndufs4 knockout mouse models: These have been extensively used to study Leigh syndrome, another mitochondrial disorder caused by Complex I deficiency. These models show progressive neurodegeneration and features resembling human Leigh syndrome

• Tissue-specific knockout models: Various tissue-specific Ndufs4 knockout mice have been developed to understand tissue-specific manifestations of mitochondrial disease

• Potential zebrafish models: Given that Carassius auratus (goldfish) MT-ND4L has been studied , zebrafish could potentially serve as a model organism for studying MT-ND4L function and mutations due to their genetic tractability and the availability of tools for mitochondrial research

Researchers interested in MT-ND4L-specific models might consider developing zebrafish or mouse models with the T10663C mutation associated with LHON to better understand its pathophysiology .

How do MT-ND4L studies contribute to our understanding of broader mitochondrial disease mechanisms?

Research on MT-ND4L provides valuable insights into several aspects of mitochondrial disease:

• Structure-function relationships in Complex I: Understanding how mutations in this small subunit can disrupt the function of the much larger Complex I provides insights into the complex's assembly and operation

• Tissue specificity of mitochondrial disorders: The association of MT-ND4L mutations with LHON, which primarily affects retinal ganglion cells, helps elucidate why certain tissues are more vulnerable to mitochondrial dysfunction than others

• Nuclear-mitochondrial interactions: Studies on how nuclear-encoded proteins interact with mitochondrially-encoded subunits like MT-ND4L provide insights into the coordinated expression and assembly of OXPHOS complexes

• Therapeutic approaches: Developing methods to restore function to mutant MT-ND4L could inform broader approaches to treating mitochondrial disorders

These studies ultimately contribute to our understanding of mitochondrial biology and the pathogenic mechanisms underlying the diverse spectrum of mitochondrial diseases .